Government of Canada / Gouvernement du Canada
Symbol of the Government of Canada


Benzodiazepines and Other Targeted Substances Regulations

Version of section 21 from 2014-11-07 to 2019-12-08:

Marginal note:Content of licence

 Subject to section 22, the Minister must, after examining the information and documents required under sections 11 and 20, issue a dealer’s licence that sets out the following particulars:

  • (a) the licence number;

  • (b) the name of the licensed dealer or, if the licensed dealer is a corporation, its corporate name;

  • (c) the activities that are permitted and, if the licence authorizes destruction, whether the licensed dealer may destroy targeted substances other than those that the licensed dealer produced, made, assembled, sold or provided;

  • (d) the address of the premises at which the licensed dealer may carry on the permitted activities;

  • (e) the targeted substance for which the activities are permitted;

  • (f) the security level and the applicable inventory limitation required at the premises referred to in paragraph (d);

  • (g) the date of issuance;

  • (h) the date of expiry;

  • (i) any conditions that are necessary to

    • (i) comply with an international obligation,

    • (ii) provide the level of security referred to in paragraph (f), or

    • (iii) reduce the potential security, public health or safety hazard, including the risk of the targeted substance being diverted to an illicit market or use;

  • (j) in the case of a producer of a targeted substance, the quantity of the targeted substance that may be produced under the licence and the period in which that quantity may be produced; and

  • (k) in the case of the maker or assembler of a product or compound that contains a targeted substance, but that is not a test kit, an annexed list that sets out the following information for each type of product or compound that may be made or assembled under the licence:

    • (i) the licence number,

    • (ii) the brand name of each product or compound,

    • (iii) the specified name of the targeted substance in each product or compound,

    • (iv) the strength per unit of the targeted substance in each product or compound, and

    • (v) the quantity or package sizes of each product or compound.

  • SOR/2010-223, s. 43(F)
  • SOR/2014-260, s. 32

Date modified: